Evidence map›Paper›PMID 33796615›Full record

ArticleBio-protocol2021

Gulcan Sahal, Herman J Woerdenbag, Wouter L J Hinrichs, Anita Visser, Henny C van der Mei, Isil Seyis Bilkay

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bio-protocol, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gulcan SahalHacettepe University, Faculty of Sciences, Department of Biology (Biotechnology Division), Beytepe, Ankara, Turkey.
Herman J WoerdenbagUniversity of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Antonius Deusinglaan 1, Groningen, the Netherlands.
Wouter L J HinrichsUniversity of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Antonius Deusinglaan 1, Groningen, the Netherlands.
Anita VisserUniversity of Groningen and University Medical Center Groningen, Department of Oral and Maxillofacial Surgery and Maxillofacial Prosthodontics, Groningen, the Netherlands.
Henny C van der MeiUniversity of Groningen and University Medical Center Groningen, Department of Biomedical Engineering, Antonius Deusinglaan 1, Groningen, the Netherlands.
Isil Seyis BilkayHacettepe University, Faculty of Sciences, Department of Biology (Biotechnology Division), Beytepe, Ankara, Turkey.
University of Groningen · NLHacettepe University · TRUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of biofilm associated candidemia for patients with implanted biomaterials causes an urgency to develop antimicrobial and biofilm inhibitive coatings in the management of recalcitrant

Indexed as

Biofilm formationBiomaterial infectionsCandidaCandidemiaEssential oil coated surfacesEssential oils

Identifiers

PMID33796615
PMCPMC8005879
OpenAlexW3135585861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.